Degenerative Disorders of the Musculoskeletal System (Chapter 38) Notes
Basic Concepts of Bone and Joint Health
Hydroxyapatite is composed of Ca^{2+} and phosphate crystals. ext{Hydroxyapatite} = ext{Ca}^{2+} ext{ and } ext{PO}_4^{3-} ext{ crystals}
Two types of bone:
Cortical (dense)
Trabecular (cancellous, spongy)
Found in high amounts in the upper femur, vertebrae, and wrist
Osteoporosis of trabecular bone displays degeneration first
Bone undergoes constant remodeling and is dependent on calcium
Hormones crucial for bone health:
Vitamin D: aids calcium absorption
Calcitonin
Parathyroid hormone (PTH)
Testosterone and estrogen
Mechanical stimulation is important for maintaining bone health
Bone Health and Calcium Homeostasis
Calcitonin is produced by the thyroid and acts to decrease blood Ca^{++} by promoting bone formation (osteoblast activity)
Parathyroid hormone (PTH) increases blood Ca^{++} by promoting bone resorption (osteoclast activity) and increasing intestinal Ca^{++} absorption
Vitamin D enhances intestinal calcium absorption and supports bone mineralization
The diagrammatic flow (conceptual):
Thyroid signals calcitonin → osteoblasts form bone; Ca^{++} stored in bone; high Ca^{++} stimulates storage in bone
Parathyroids secrete PTH → osteoclasts resorb bone → Ca^{++} released into blood
Intestines absorb Ca^{++} (influenced by Vitamin D) to maintain normal blood Ca^{++}
Summary: calcium homeostasis involves hormonal regulation (calcitonin, PTH, vitamin D) and mechanical cues to remodel bone appropriately
Joints and Arthropathy
Types of joints:
Synarthrosis: no mobility
Diarthrosis (synovial): most movement
Amphiarthrosis: moderately movable
Arthropathy = joint disorder
Arthritis = inflammation of a joint
Degeneration of Bone and the Osteoporosis Paradigm
Bone remodeling: destruction (osteoclasts) and reconstruction (osteoblasts)
Remodeling is stimulated by stresses on bone
Osteoporosis = elevated osteoclast activity without adequate bone replacement
Recommended calcium intake for bone health: 1{,}000 ext{–} 1{,}200 ext{ mg/day}
Osteoporosis: Key Concepts and Risk Factors
Osteoporosis and osteopenia definitions:
Osteoporosis: porous bone with low bone density and structural deterioration
Osteopenia: thinning of the trabecular matrix (occurs before osteoporosis)
Osteoporosis is often a silent disease and may present with pathological fracture or height loss
Hip fractures carry increased mortality risk:
Mortality risk is 2.8 ext{ to } 4 times greater in the first 3 months after fracture
Nearly 1 ext{ in } 4 fracture patients die within 12 months after fracture
Osteoporosis: Diagnosis, Risk, and Hormonal Influence
Risk factors include:
Female gender, postmenopausal age, lack of estrogen, lack of testosterone in males
Family history, Asian/Caucasian women, thin/small-framed women
Inadequate daily calcium and vitamin D, lack of weight-bearing exercise
Excess alcohol, caffeine; smoking
Long-term corticosteroid use; high carbonated drink intake; gastric bariatric surgery; eating disorders (e.g., anorexia)
Hyperthyroidism or excessive thyroid medication; hyperparathyroidism; anticonvulsant medications
Hormonal influences on bone mineral density (BMD):
Estrogen slows osteoclast activity (protects bone) and may be implicated in the female athlete triad (amenorrhea, low body weight, excessive exercise)
Diagnostic tools:
Dual-energy X-ray absorptiometry (DEXA) to measure BMD; results reported as a T score; compared to a reference population of healthy adults around age 30
X-ray may not show osteoporosis until bone loss exceeds ~40 ext{%}
Blood tests: PTH, estradiol, osteocalcin (a marker of bone turnover)
Urine tests: telopeptides (bone breakdown products)
FRAX risk assessment: self-assessment tool predicting a 10-year fracture risk for spine, hip, shoulder, or wrist in ages 40–90
BMD and diagnosis specifics:
Osteoporosis diagnosis relies on BMD measurements and fracture risk tools; T score is used in reporting
Treatment modalities (summary):
Lifestyle: Diet with 1{,}000 ext{ mg} calcium and 400 ext{ IU} vitamin D; UV exposure; weight-bearing exercise
Antiresorptive agents: Bisphosphonates; SERMs (selective estrogen receptor modulators); Denosumab
Anabolic/other therapies: Parathyroid hormone analogs (e.g., teriparatide); Calcitonin; Biologic agents
Calcitonin can increase bone formation and is effective for vertebral compression fractures
Teriparatide stimulates osteoblast activity
Vertebroplasty involves injecting bone cement into fractured vertebral areas
Osteoporosis: special notes on evaluation
X-rays reveal osteoporosis only after substantial bone loss
FRAX score helps quantify 10-year fracture probability
Osteoporosis: Continued Therapeutics and Outcomes
Anti-resorption agents and risks:
Bisphosphonates have historically been used but have associations with atypical fractures
Other options: SERMs, Denosumab
Hormonal influences: estrogen deficiency after menopause contributes to increased osteoclast activity; hormone-related risk factors are part of the broader osteoporosis risk profile
Osteoarthritis (OA): Overview and Pathophysiology
OA typically presents in individuals older than 40 years and is slowly progressive, degenerative, and inflammatory
Primary driver: changes in articular cartilage lead to inflammation and joint surface changes; excess body weight increases risk in weight-bearing joints
Commonly affected joints include the cervical and lumbosacral spine, hip, knee, and the 1st metatarsophalangeal (MTP) joint
Wrists, elbows, and ankles are often spared
OA Risk Factors and Presentation
Risk factors:
Aging
Obesity
History of participation in team sports
History of trauma or overuse of a joint
Heavy occupational work
Pelvic/leg misalignment (pelvis, hip, knee, ankle, or foot)
Clinical presentation:
Deep, aching joint pain
Pain relieved with rest
Joint pain worsened by cold weather
Morning stiffness that resolves with movement
Crepitus on motion
Joint swelling and altered gait
Limited range of motion
OA: Physical Exam Findings and Diagnostic Features
Physical exam findings:
Joint deformity and tenderness
Decreased range of motion
Heberden's nodes at the distal interphalangeal joints (DIPs)
Bouchard's nodes at the proximal interphalangeal joints (PIPs)
Diagnosis:
No specific laboratory test confirms OA
Serum markers can include osteocalcin and hyaluronic acid (not definitive)
X-rays show structural changes: joint space narrowing and osteophyte formation
OA Treatments:
NSAIDs; intra-articular corticosteroid injections or topical steroids as alternatives
Maintain mobility with moderate exercise
Dietary supplements such as chondroitin sulfate
Strategies to reduce stress on joints (weight loss, activity modification)
Surgical options for advanced OA:
Osteotomy (removal of bone spurs)
Osteoplasty (scraping/removal of deteriorated tissue)
Arthrodesis (spinal fusion)
Partial or total joint arthroplasty (prosthetic joint replacement)
Rickets: Pediatric Vitamin D Deficiency Syndromes
Affects children (infants 4–12 months)
Core deficiencies: vitamin D, calcium, phosphorus
Consequences of deficiency:
Lack of vitamin D reduces calcium absorption; if Ca^{++} falls, parathyroid hormone (PTH) is secreted, promoting bone breakdown
Food vitamin D supplementation has reduced rickets incidence
Risk factors: lactose intolerance, malabsorption, malnutrition
Malformations include:
Protrusion of sternum
Varus deformity (bowing) of the legs
Costochondral enlargements
Delayed fontanelle closure, delayed tooth development
Rickets: Diagnosis and Treatment
Diagnosis:
Serum calcium, PTH, and alkaline phosphatase levels
X-rays showing bone deformity
Treatment:
Vitamin D supplementation: 400 ext{ to } 1{,}000 ext{ IU/day}
Adequate calcium intake
Daily UV exposure
Osteomalacia: Adult Vitamin D Deficiency
Similar to rickets but occurs in adults; etiologies include insufficient sun exposure, renal disorders, cancer, malabsorption
Pathophysiology:
Vitamin D deficiency reduces calcium absorption → PTH release → bone breakdown
Results in bone weakness and back/bone pain, especially with activities like climbing stairs
Diagnosis:
Blood tests for vitamin D, PTH, and alkaline phosphatase
DEXA scan
X-ray findings may include pseudofractures (Looser’s zones), subperiosteal resorption, cortical thinning, and increased bone porosity
Treatment:
Ergocalciferol (vitamin D2) 50,000 IU until normalized
Maintenance: 1,000 IU vitamin D3 daily
Adequate sunlight exposure and increased dietary calcium
Degenerative Disc Disease (DDD): Overview
A common cause of pain, motor weakness, and neuropathy
Pathophysiology:
Intervertebral discs distort and can compress spinal nerves
Most affected regions: cervical and lumbar, especially L4–L5 and S1
DDD: Signs, Symptoms, and Nerve Impingement
Lumbar DDD signs:
Low back pain radiating down the posterior leg (sciatica)
Buttock or thigh pain
Pain worsened by sitting, bending, lifting, or twisting; relieved by walking or changing position or lying down
Numbness, tingling, weakness in legs; possible foot drop
Cervical DDD signs:
Chronic neck pain radiating to shoulders/arms
Numbness or tingling in arms/hands
Arm/hand weakness
Spinal nerve impingement spectrum:
Herniated disc, bulging disc, or degenerated disc
Osteophyte formation can narrow the spinal canal (spinal stenosis)
Vertebral slippage: spondylolisthesis (forward) or retrolisthesis (backward)
DDD: Physical Examination and Diagnosis
Physical exam components:
Muscle strength testing
Deep tendon reflexes
Sensory dermatomes to localize affected nerve
Diagnostic tools:
Physical examination findings
Imaging: X-ray, MRI
Electromyography (EMG) for nerve/ muscle involvement
DDD: Treatment and Management
Treatments include:
Physical therapy
Pain management strategies
Epidural steroid injections
Chiropractic care
Surgical options for refractory cases
Spinal Stenosis and Cauda Equina Syndrome
Spinal stenosis: anatomical narrowing of the spinal canal, nerve root canal, and intervertebral foramina; develops gradually
Symptoms mimic disc herniation but are due to canal narrowing
Diagnosis: X-ray, MRI
Treatment: pain management
Cauda equina syndrome: compression of lumbosacral nerves leading to bowel/bladder dysfunction; a medical emergency requiring urgent evaluation and intervention
Connections to Foundational Principles and Real-World Relevance
Bone remodeling and calcium homeostasis connect endocrine regulation (PTH, calcitonin, vitamin D, estrogen/testosterone) with mechanical loading and aging
Osteoporosis exemplifies how aging, hormones, nutrition, and lifestyle converge to affect fracture risk and mortality
OA highlights how mechanical wear, inflammatory processes, and joint anatomy determine distribution and progression
Rickets and osteomalacia demonstrate the crucial role of vitamin D in calcium metabolism and skeletal integrity across life stages
DDD illustrates the neuroanatomical consequences of disc degeneration and the spectrum of nerve impingement disorders
Ethical, Practical, and Public Health Implications
Emphasis on prevention: adequate calcium/vitamin D intake, weight-bearing exercise, smoking cessation, limiting excessive alcohol and caffeine
Access to diagnostic tools (DEXA, MRI) and treatments (bisphosphonates, injections, surgical options) impacts outcomes
Public health importance of sunlight exposure balanced with skin cancer risk and cultural practices
Managing chronic musculoskeletal conditions requires interdisciplinary care (medicine, physical therapy, nutrition, orthopedics)
Quick Reference: Selected Numerical Details
Daily calcium intake recommended: 1{,}000 ext{–}1{,}200 ext{ mg/day}
Vitamin D supplementation commonly recommended: 400 ext{ IU/day} (dietary) and 1{,}000 ext{ IU/day} (maintenance for certain deficiency states; high-dose initial therapy may use 50{,}000 ext{ IU} ergocalciferol until normalized)
Hip fracture mortality risk within 3 months: 2.8 ext{–}4 imes baseline
FRAX assesses 10-year fracture risk (ages 40–90)
Osteophytes are a hallmark radiographic feature of OA
Heberden’s nodes: DIP involvement in OA
Bouchard’s nodes: PIP involvement in OA
Osteoporosis diagnostic imaging: DEXA measures BMD; X-ray may show changes after significant bone loss (often >40 ext{%})
Diagnostic markers for OA include serum osteocalcin and hyaluronic acid (not definitive)
Rickets/osteomalacia diagnostic markers: serum calcium, PTH, alkaline phosphatase; vitamin D status; X-ray deformities; Looser’s zones in osteomalacia
DDD imaging: MRI and EMG often aid in identifying nerve involvement and guiding treatment
Here are the meanings of some medical words related to bone and joint health:
Hydroxyapatite: Composed of ext{Ca}^{2+} and phosphate crystals, it is a primary mineral component of bone.
Osteoporosis: A condition characterized by porous bone with low bone density and structural deterioration, leading to increased fracture risk.
Osteopenia: A thinning of the trabecular matrix, which occurs before osteoporosis.
Arthropathy: A general term for any joint disorder.
Arthritis: Inflammation of a joint.
Rickets: A pediatric condition caused by vitamin D, calcium, or phosphorus deficiency, leading to bone malformations in children.
Osteomalacia: A condition similar to rickets but occurring in adults, resulting in bone weakness due to vitamin D deficiency.
Osteophytes: Also known as bone spurs, these are bony outgrowths that can form on joints, often seen in osteoarthritis.
Heberden's nodes: Bony enlargements at the distal interphalangeal joints (DIPs) of the fingers, a clinical sign of osteoarthritis.
Bouchard's nodes: Bony enlargements at the proximal interphalangeal joints (PIPs) of the fingers, also associated with osteoarthritis.
Degenerative Disc Disease (DDD): A common cause of pain, motor weakness, and neuropathy due to the distortion and compression of spinal nerves by intervertebral discs.
Spinal stenosis: An anatomical narrowing of the spinal canal, nerve root canal, and intervertebral foramina that develops gradually.